Background: several epidemiological studies have suggested that polymorphisms of the Excision Repair Cross Complementing Group-5 (ERCC5) gene might be related to gastric cancer risk; however, the results have been inconsistent or controversial. Therefore, we have performed a systematic review and meta-analysis to clarify the association between the ERCC5 gene polymorphisms and gastric cancer risk. Materials and Methods: An electronic search was conducted of several databases, including PubMed, Web of Science, and Google Scholar for articles that describe the association between polymorphisms of the ERCC5 gene and susceptibility of gastric cancer. Results: A total of 33 case control studies in 15 publications were included in the present meta-analysis. There were significant associations between gastric cancer susceptibility and 
Introduction
Gastric cancer is the 4th most common and 2th leading cause of cancer-associated mortality, accounting for 10.4% of all cancer deaths worldwide (Yaghoobi et al., 2017) . Gastric cancer remains highly prevalent and accounts for a notable proportion of global cancer mortality. It is estimated that nearly 951,000 new gastric cancer cases and 723,000 deaths were occurred in 2012 (Ferlay et al., 2012; Torre et al., 2015) . Despite the observed declines in the gastric cancer incidence, it causes one of the highest cancer burdens, as measured by disability-adjusted life years lost in several Asian and Central and South American (CSA) countries (Karimi et al., 2014; Sierra et al., 2016) . It is well established that a number of risk factors including dietary and nutritional aspects, genetic predisposition and sporadically-occurring mutations, and Helicobacter pylori , Hossein Neamatzadeh 6 infection predispose to the development of gastric cancer 6-8. It has been estimated that 10% of gastric cancer cases show familial clustering; however, inherited component contributes to 1-3% of gastric cancers (Oliveira et al., 2004; Sierra et al., 2016) .
The excision repair cross complementing group 5 (ERCC5) gene (also known as XPG; UVDR; XPGC; COFS3; ERCM2; ERCC5-201) is located on the human chromosome 13q32-33, which encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage (Kiyohara et al., 2007; Ma et al., 2012; Wang et al., 2013) . ERCC5 (XPG DNA repair endonuclease) gene is an indispensable component of the nucleotideexcision repair (NER) pathway, which belongs to the flap structure-specific endonuclease 1 (FEN1) family (Kiyohara et al., 2007; Wang et al., 2013) . ERCC5 is one of the main genes activated by p53 and are involved in DNA repair (Kannan et al., 2000; . Mutations in the ERCC5 gene cause either the cancer-prone disorders Xeroderma Pigmentosum (XP), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer following UV exposure, or the severe neurodevelopmental disorder Cockayne syndrome (CS) (Ma et al., 2012; Wang et al., 2013) . There is considerable evidence that some single nucleotide polymorphisms (SNPs) of ERCC5 gene are correlated to gastric cancer occurrence. However, the associations between ERCC5 gene polymorphisms and gastric cancer risk were still conflicting. Therefore, in the present systematic review and meta-analysis the association between polymorphisms of ERCC5 gene and gastric cancer susceptibility were comprehensively estimated.
Materials and Methods

Study Identification and Selection
A computerized literature search was conducted for the relevant available studies published in PubMed, Web of Science, EMBASE, and Google scholar. The literature search was updated on May 15, 2017. The search strategy identified all possible studies using combinations of the following keywords: ''excision repair cross complementing group 5 gene'', ''ERCC5 gene'', ''XPG gene'', ''rs751402 C>T'', ''rs2296147 T>C'', ''rs873601 G>A'', ''rs2094258 C>T'', ''rs1047768 T>C'', ''polymorphism'', ''genotype'', ''variant'', ''mutation'', ''gastric cancer'', and ''stomach cancer'. The reference lists of retrieved publications, review articles and previous meta-analyses, were also hand-searched for collecting other relevant studies that was missed in the electronic search.
Eligibility Criteria
The following inclusion criteria were used in selecting literature for the current meta-analysis: (1) evaluation of the association between ERCC5 gene polymorphisms and gastric cancer; (2) studies with a case-control or cohort design; (3) sufficient published data for calculating odds ratios (ORs) with their 95% confidence intervals (95% CIs); and (4) studies published in English or Chinese. If multiple studies from the same case series were available, the one including the most individuals was used in the analysis. We excluded the studies if they were: (1) only abstracts, review articles, case reports, or editorials; (2) conducted on animals; (3) not designed as case-control or cohort studies; (3) not offering the essential data; (4) control population including gastric cancer patients or other disorders; (5) duplicate of previous publications.
Data Extraction
Data were independently extracted by two authors and then examined by an expert in headaches. From each of the included articles the following data were collected: first author, year of publication, country origin, ethnicity, total number of cases and controls, the frequencies of genotypes in case and control groups, minor allele frequencies (MAFs), P-value for Hardy-Weinberg equilibrium (HWE). In case of disagreement, consensus was obtained on every item by joint review of the study.
Statistical Analyses
The strength of association between ERCC5 gene polymorphisms and risk of gastric cancer was measured by odds ratios (ORs) and 95% confidence intervals (CIs) under five genetic models. Additionally, the strength of associations was assessed by using ORs and 95% CIs and the significance of pooled ORs was examined by Z test. Heterogeneity between studies was evaluated by Q test and I2 statistics. P < 0.10 or I2 > 50% indicated significant heterogeneity (Khoram-Abadi et al., 2016; Mehdinejad et al., 2017; . If substantial heterogeneity was detected, the random effects model (DerSimonian-Laird method) was used; otherwise the fixed effects model (the Mantel-Haenszel method) was utilized (DerSimonian et al., 1986) . Hardy-Weinberg equilibrium (HWE) tests for the ERCC5 gene polymorphisms in the control groups were examined using chi-square test. If P value > 0.05, the genotype distribution of the control group conformed to HWE. Sensitivity analysis was conducted to assess the stability of the current meta-analysis results, namely, a single study in the present meta-analysis was omitted each time to reflect the influence of the individual data set to the pooled OR. Furthermore, to explore the source of between-study heterogeneity, the sensitivity analysis was performed by omission of studies deviated from HWE (Sadeghiyeh et al., 2017) . Publication bias was examined using both qualitative Begg's funnel plot and quantitative Egger test were used to assess publication bias and the significance level was set at 0.05 for both (Begg et al., 1994; Egger et al., 1997) . All the statistical analyses were performed by comprehensive meta-analysis (CMA) version 2.0 software (Biostat, USA). All p-values were two-tailed with a significant level at 0.05.
Results
Study Characteristics
Initially, we have identified 28 publications through the database search. After reading the titles and abstracts, three publications with duplicate titles and four articles that were review articles or assessed unrelated diseases were excluded. Finally, a total of 33 case-control studies in 15 publications were identified met our inclusion criteria. Of those, there were ten case-control studies (Chen et al., 2016; Duan et al., 2015; Feng et al., 2016; Guo et al., 2016; He et al., 2012; Li et al., 2016; Lu et al., 2016; Yang et al., 2016; Zhou et al., 2016) with 4664 cases and 5150 controls concerning rs751402 C>T polymorphism, seven case-control studies (Chen et al., 2016; Feng et al., 2016; He et al., 2012; Lu et al., 2016; Yang et al., 2016; Yang et al., 2012) with 3812 cases and 4177 controls concerning rs2094258 C>T polymorphism, six case-control studies (Bai et al., 2016; He et al., 2012; Hussain et al., 2009; Li et al., 2014; Li et al., 2016) with 3064 cases and 3413 controls concerning rs1047768 T>C polymorphism, five
Quantitative Synthesis Results
The meta-analysis findings of the correlation between ERCC5 gene polymorphisms and gastric cancer risk are summarized in Table 2 case-control studies (Chen et al., 2016; Duan et al., 2015; He et al., 2012; Yang et al., 2016) with 3699 cases and 3890 controls concerning rs2296147 T>C polymorphism, and five case-control studies (Chen et al., 2016; He et al., 2012; Zhou et al., 2016; Yang et al., 2016) with 3727 cases and 3918 controls concerning rs873601 G>A polymorphism. The alleles and genotypes distribution for ERCC5 gene polymorphisms in case group and control group of all studies were included in Table 1 . The genotypes distribution frequencies among the controls were in agreement with HWE for all included articles except for three case-control studies (Table 1) 
MAFs
The minor allele frequencies (MAFs) in the healthy subjects were calculated from the corresponding genotype distribution (Table 1) . Frequencies of the rs751402 C>T, rs2094258 C>T, rs1047768 T>C, rs2296147 T>C and rs873601 G>A alleles were 0. 278-0.396, 0.282-0.762, 0.270-0.291, 0.191-0.276, and 0.463-0 .500, respectively.
Sensitivity Analysis
We have performed a sensitivity analysis by removing the individual studies sequentially to assess the effect of individual studies. The results detected did not differ from the initial analysis. Moreover, we have performed sensitivity analysis by omitting four studies in which the genotype distributions of ERCC5 gene polymorphisms in the control groups significantly deviated from the HWE (p<0.005). However, the significance of pooled ORs not influenced by omitting the studies, indicating that our results was stable and reliable.
Publication Bias
Begg's funnel plot and Egger's test were used to assess the publication bias in the current meta-analysis. The Funnel plots' shape did not reveal obvious evidence of asymmetry. The results of Egger's test statistically confirmed the absence of publication bias for rs2094258 C>T, rs1047768 T>C, rs2296147 T>C and rs873601 G>A polymorphisms. However, the results of Egger's test statistically showed evidence of publication bias for rs751402 C>T under all five genetic models (T vs. C: P Beggs = 0.152, P Eggers = 0.033; TT vs. CC: P Beggs = 0.175, P Eggers = 0.032; TC vs. CC: P Beggs = 0.152, P Eggers = 0.015; TT+TC vs. CC: P Beggs = 0.107, P Eggers = 0.017; and TT vs. TC+CC: P Beggs = 0.020, P Eggers = 0.006; Table 2, Figure 2 ).
Discussion
To date, several single nucleotide polymorphisms (SNPs) in ERCC5 gene have been identified, and have been studied for their association with different cancer risk, such as rs751402 C>T, rs2296147 T>C, rs873601 G>A, rs2094258 C>T, rs1047768 T>C, rs17655G>C, rs2018836G>A, and rs3818356G>A (Chen et al., 2016; Guo et al., 2016; Feng et al., 2016) . Of these, we have found that five polymorphisms including rs751402 C>T, rs2094258 C>T, rs1047768 T>C, rs2296147 T>C, and rs873601 G>A most frequently investigated for their associations with risk of gastric cancer (Chen et al., 2016; Duan et al., 2015; Feng et al., 2016; Guo et al., 2016; He et al., 2012; Li et al., 2016; Lu et al., 2016; Yang et al., 2016; Zhou et al., 2016) . Interestingly, rs17655G>C (Asp1104His) polymorphism as the most widely studied polymorphism of ERCC5 gene in various cancers not investigated in the gastric cancer.
In the current meta-analysis, a total of 33 case control studies in 15 publications with 16,783 cancer cases and 23,063 controls were selected. When all the studies were pooled together, our results suggested that the ERCC5 gene rs751402 C>T, rs2296147 T>C, and rs873601 G>A polymorphisms are associated with risk of gastric cancer, however, this risk was not observed for the other two SNPs (rs2094258 C>T and rs1047768 T>C). In a most recent meta-analysis based on 47 case-control studies, Huang et al., (2017) showed ERCC5 gene rs873601 G>A polymorphism was significantly associated with an increased risk of different cancers. However, they have found only two rs751402 C>T and rs873601 G>A polymorphisms were significantly associated with an increased risk of gastric cancer. Na et al., (2015) in a case control study reported that rs751402 C>T, rs2296147 Table 2 . The Meta-Analysis of XPG Polymorphisms and Gastric Cancer Risk T>C, and rs873601 G>A polymorphisms not significantly associated with risk of breast cancer in a Chinese population. In another study, have found that rs2094258 C>T, rs751402 C>T, and rs873601 G>A polymorphisms were significantly associated with colorectal cancer susceptibility. However, they have identified a protective association between rs751402 C>T and risk of colorectal cancer. Zhu et al., (2012) in a case-control study of 1,115 esophageal squamous cell carcinoma (ESCC) cases found that the rs2296147 T>C polymorphism was associated with ESCC risk; however, they have not observed this risk for rs2094258C>T and rs873601 G>A polymorphism. This result could be interpreted partially on the basis of the different functions of ERCC5 gene (such as RNA polymerase II transcription, and transcription-coupled DNA repair) in different tumor types as a result of distinct mechanisms in terms of cancer susceptibility. On the other hand, it seems this probability may be that different types of cancer may have different mechanism of carcinogenesis (Yazdi et al., 2015) . We have found statistically significant level of heterogeneity predominantly for rs751402 C>T and rs2296147 T>C polymorphisms, which might have distorted the results. Heterogeneity may be due to many factors, such as study characteristics, small sample size, source of controls, genotyping methods and difference in clinical and/or environmental factors (Jia et al., 2017; Jafari-Nedooshan et al., 2017; Kamali et al., 2017; Sobhan et al., 2017 ). In the current meta-analysis subgroup analysis to better ensure the reliability of our results and identifying source of heterogeneity not explored due lack of original data. However, we suggested that the interaction between two or more polymorphisms might be representing an additional source of heterogeneity in the current meta-analysis.
To the best knowledge this was the first particular meta-analysis conducted to evaluate the association between ERCC5 gene polymorphisms and gastric cancer risk. However, in interpreting results of the current meta-analysis, some limitations should be acknowledged. First, although the sample size of our study was relatively large, the statistical power was still limited only to the Chinese populations, which produced selection bias at the start of the current meta-analysis. Therefore, studies with larger sample sizes in other ethnicities should be undertaken to validate our findings. Second, in the current meta-analysis we have included only articles in English and Chinese language; thus, studies written in other languages were neglected. Third, although we have performed a comprehensive search to identify eligible studies for current meta-analysis, it was still possible that a few studies meeting inclusion criteria were not included, which could to cause publication bias. Third, because of the lack of original data, we did not conduct a more precise analysis based on single-factor estimates without adjustment for age, sex, histological type, environmental factors and other risk factors (e.g. nutritional behavior, smoking, drinking status), which may cause serious confounding bias. Hence, a precise analysis should be performed if the individual data were available. Finally, it is essential to examine the gene-environment and gene-gene interactions at the levels of individual studies and meta-analysis. To achieve this goal, one usually needs to perform a meta-analysis of individual data, which is not always practical for the majority of available metaanalyses. However, our meta-analysis did not evaluate any potential gene-gene interaction and gene-environment interaction due to lack of relevant published data.
In conclusion, our findings provide clear evidence that ERCC5 gene rs751402 C>T, rs2296147 T>C, and rs873601 G>A polymorphisms are associated with the susceptibility of gastric cancer, but not rs2094258 C>T and rs1047768 T>C. Further well-designed studies with larger sample sizes in the different ethnic groups will be necessary to validate the findings in the current metaanalysis.
